Cytarabine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71288-168 -
Package NDC
71288-168-50 -
Application number
ANDA206190 -
SPL ID
038a9b4b-a951-4c8c-be74-00a4a64eedd1 -
SPL set ID
1be2668b-d76f-4c65-aea9-86c5c40889a2 -
UNII
04079A1RDZ -
RxCUI
240416
What the source publishes
- Labeler
- Meitheal Pharmaceuticals Inc.
- Active ingredients
- Cytarabine
- Form
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cytarabine",
"splId": "038a9b4b-a951-4c8c-be74-00a4a64eedd1",
"labels": [
{
"setId": "1be2668b-d76f-4c65-aea9-86c5c40889a2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1be2668b-d76f-4c65-aea9-86c5c40889a2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1be2668b-d76f-4c65-aea9-86c5c40889a2"
}
],
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"labeler": "Meitheal Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, MULTI-DOSE in 1 CARTON (71288-168-50) / 50 mL in 1 VIAL, MULTI-DOSE",
"package_ndc": "71288-168-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20171109"
}
],
"productId": "71288-168_038a9b4b-a951-4c8c-be74-00a4a64eedd1",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "71288-168",
"deaSchedule": null,
"genericName": "Cytarabine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CYTARABINE",
"strength": "20 mg/mL"
}
],
"applicationNumber": "ANDA206190",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171109",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000233",
"N0000175595"
],
"unii": [
"04079A1RDZ"
],
"rxcui": [
"240416"
],
"spl_set_id": [
"1be2668b-d76f-4c65-aea9-86c5c40889a2"
],
"pharm_class_epc": [
"Nucleoside Metabolic Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleic Acid Synthesis Inhibitors [MoA]"
],
"manufacturer_name": [
"Meitheal Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71288-168_038a9b4b-a951-4c8c-be74-00a4a64eedd1"